Persistent Elevation of Thyroglobulin in Patient Treated for Differentiated Thyroid Cancer: A Ten-Year Review.
Authors:
- 20 September 2018
- journal article
- review article
- Vol. 114 (5) , 387-393
Abstract
Differentiated Thyroid Cancer (DTC) is increasing in prevalence due to better diagnostic tools and excellent long-term survival. This study is to understand the outcome of twenty-six patients with DTC over a period of 10 years after the initial treatment with surgery and radioiodine therapy. Our study analysis showed no deaths, and indicated that older men were more likely to have persistent disease. Further studies are needed to focus on cost effective long-term management of DTC.Keywords
This publication has 14 references indexed in Scilit:
- Multistage carcinogenesis and the incidence of thyroid cancer in the US by sex, race, stage and histologyBMC Public Health, 2015
- Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant MetastasisMedicine, 2015
- Thyroglobulin antibody status and differentiated thyroid cancerCurrent Opinion in Oncology, 2015
- Practice Trends in Patients with Persistent Detectable Thyroglobulin and Negative Diagnostic Radioiodine Whole Body Scans: A Survey of American Thyroid Association MembersThyroid®, 2014
- Conservative management of thyroglobulin-positive, nonlocalizable thyroid carcinomaHead & Neck, 2013
- Measurement of Thyroglobulin by Liquid Chromatography–Tandem Mass Spectrometry in Serum and Plasma in the Presence of Antithyroglobulin AutoantibodiesClinical Chemistry, 2013
- Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic OutcomeJournal of Korean Medical Science, 2012
- Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 PatientsThe Journal of Clinical Endocrinology & Metabolism, 2011
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Persistent Disease in Patients with Papillary Thyroid Carcinoma and Lymph Node Metastases After Surgery and Iodine‐131 AblationWorld Journal of Surgery, 2007